Sean Bevick
Vice President, Investor Relations
Replay available
Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call
Quest Diagnostics Incorporated (NYSE: DGX) Q2 2025 earnings conference call, held 2025-07-22. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Sam Samad
Chief Financial Officer
Jim Davis
Chairman, Chief Executive Officer and President
Anne Hines
Analyst, Mississippi Securities
Kevin Caliendo
Analyst, UBS
Elizabeth Anderson
Analyst, Evercore ISI
Erin Wright
Analyst, Morgan Stanley
Michael Turney
Analyst, Learing Partners
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Quest Diagnostics Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.016 with all rights reserved. Any redistribution, retransmission, or rebroadcast of this 00:00:05.016 -- 00:00:10.899 call in any form without the written consent of Quest Diagnostics is strictly prohibited. 00:00:11.081 -- 00:00:15.385 Now, I'd like to introduce Sean Bevick, Vice President of Investor Relations for Quest 00:00:15.385 -- 00:00:17.385 Diagnostics. 00:00:18.067 -- 00:00:20.149 Please go ahead. 00:00:20.149 -- 00:00:24.373 Thank you and good morning. I'm joined by Jim Davis, our Chairman, Chief Executive Officer 00:00:24.373 -- 00:00:28.094 and President, and Sam Samad, our Chief Financial Officer. 00:00:28.094 -- 00:00:32.699 During this call, we may make forward-looking statements and will discuss non-GAAP measures. 00:00:32.699 -- 00:00:36.944 We provide a reconciliation of non-GAAP measures to comparable GAAP measures in the tables 00:00:36.944 -- 00:00:39.006 to our earnings press release. 00:00:39.006 -- 00:00:42.570 Actual results may differ materially from those projected. 00:00:42.570 -- 00:00:47.376 Risks and uncertainties that may affect Quest Diagnostics' future results include, but 00:00:47.376 -- 00:00:52.762 are not limited to, those described in our most recent annual report on Form 10-K, 00:00:52.762 -- 00:00:59.304 and subsequently filed quarterly reports on Form 10-Q, and current reports on Form 8K. 00:00:59.304 -- 00:01:04.332 For this call, references to reported EPS refer to reported diluted EPS, 00:01:04.332 -- 00:01:08.900 and references to adjusted EPS refer to adjusted diluted EPS. 00:01:08.900 -- 00:01:13.367 Growth rates associated with our long-term outlook projections, including consolidated 00:01:13.367 -- 00:01:18.275 revenue growth, revenue growth from acquisitions, organic revenue growth,...